CAR-T cell therapy cost in China
Reported CAR-T cell therapy prices in China range from about $65,000 to $181,690 (USD) across 8 sourced entries (2024, 2025, 2026). Sources differ; we never average them.
All entries
| Amount | City / hospital | Includes | Patient type | Year | Source | Status |
|---|---|---|---|---|---|---|
| $150,000 to $180,000 | - | cell collection and manufacturing, hospital admission, reported treatment episode | international-dept | 2026 | AFP / Free Malaysia Today | Reported Last verified |
| $65,000 | - | CAR-T treatment, full patient journey as reported | international-dept | 2026 | AFP / Free Malaysia Today | Reported Last verified |
| ¥999,000 to ¥1,290,000 about $140,704 to $181,690 | - | List price per infusion of CAR-T products approved in China (drug only), Excludes procedure, hospitalization and facility costs, National list prices, not hospital-specific | unknown | 2024 | International Journal of Health Policy and Management (via PMC) | Reported Last verified |
| ¥1,200,000 about $169,014 | - | Domestic list price of axicabtagene ciloleucel (Yikaida), China's first approved CAR-T product, per infusion, Drug price only; hospital stay and monitoring not stated, Manufacturer outcome-based plan refunds up to CNY 600,000 if complete remission is not reached (2024 report) | unknown | 2024 | Securities Times (citing National Business Daily) | Reported Last verified |
| $150,000 to $180,000 | - | single CAR-T infusion (equivalent to US product) | unknown | 2026 | The Straits Times / Bloomberg | Reported Last verified |
| $65,000 | shanghai | clinical trial treatment, hospital care, airfare | international-dept | 2025 | The Straits Times / Bloomberg | Reported Last verified |
| ¥990,000 about $139,437 | shanghai | single CAR-T injection for solid tumor | unknown | 2026 | The Insight Asia / Caijing | Reported Last verified |
| $65,000 | - | treatment, hospital accommodation for patient, meals for two, airport transport | unknown | 2025 | Facebook group: MULTIPLE MYELOMA SUPPORT GROUP | Self-reported Last verified |
What to watch
- Includes differ: some entries cover the treatment only, others the whole journey
- International-department pricing differs from local self-pay pricing
- Currency conversions carry the rate date of the entry; recheck before budgeting
Sources
- China lures foreign patients with cutting-edge, cheap medical care
“New Zealand patient Stuart Lye's total cost was reported around USD 65,000.”
- A New Outcomes-Based Payment Plan From a Chinese Company to Improve Patient Affordability of CAR-T Product
“The current list pricing ranges between 0.999 million and 1.29 million RMB per infusion, far more expensive than standard-of-care therapies.”
- Gilead's Kite exits China cell therapy JV with Fosun Pharma
“The list price for Yescarta in China is 1.2 million yuan (about $170,000).”
- 价格高达百万元的CAR-T产品如何打通“最后一公里”？
“奕凯达是中国首款获批的CAR-T细胞治疗产品，国内定价为120万元一针。”
- China Focus: More health insurance coverage for cancer patients in China
“it was once priced at over 1 million yuan per infusion.”
Information only. Not medical advice, diagnosis or a treatment recommendation. Talk to your doctor. In an emergency, call your local emergency number.